Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Plotinus's Profile
Displaying 51-100 of 630 result(s).
CYDY CytoDyn Inc
11/25/2024 10:47:15 PM
3 years sounds crazy because it isâ (5)
CYDY CytoDyn Inc
11/25/2024 10:38:19 PM
OHM20 has mentioned the other key f (6)
CYDY CytoDyn Inc
11/25/2024 10:11:19 PM
No way this trial takes a year to e (22)
CYDY CytoDyn Inc
11/25/2024 11:22:00 AM
I tend to agree and you have to let (18)
CYDY CytoDyn Inc
11/23/2024 9:42:42 AM
I agree it would have been best to (5)
CYDY CytoDyn Inc
11/22/2024 12:04:59 PM
Yes… I am blocked out. I sent an (2)
CYDY CytoDyn Inc
11/22/2024 10:03:18 AM
The Leronlimab doses are listed on (4)
CYDY CytoDyn Inc
11/22/2024 9:42:26 AM
Oops…3 hours early
CYDY CytoDyn Inc
11/22/2024 9:35:51 AM
I am unable to get into the Cytodyn
CYDY CytoDyn Inc
11/22/2024 7:18:44 AM
Cardamine, just to clarify that in (13)
CYDY CytoDyn Inc
11/21/2024 4:06:57 PM
A couple of comments after attendin (24)
CYDY CytoDyn Inc
11/14/2024 9:27:34 AM
It would be of interest to see the (25)
CYDY CytoDyn Inc
11/13/2024 7:16:04 PM
Thanks for the link Drano, the edit (19)
CYDY CytoDyn Inc
11/04/2024 12:06:41 PM
I am looking for those details also (1)
CYDY CytoDyn Inc
11/04/2024 10:12:25 AM
On the timing, not surprised, expec (5)
CYDY CytoDyn Inc
11/04/2024 9:03:44 AM
I checked clinical trials.gov just (10)
CYDY CytoDyn Inc
11/01/2024 9:23:29 AM
I had a thought to complete the REC (20)
CYDY CytoDyn Inc
10/30/2024 8:38:40 AM
There are going to be many more mil (5)
CYDY CytoDyn Inc
10/20/2024 1:55:01 PM
Intuition…advantage women…much (1)
CYDY CytoDyn Inc
10/20/2024 1:51:39 PM
“The neurons in his right hemisph (6)
CYDY CytoDyn Inc
10/20/2024 12:40:36 PM
I would say sex is a variable on th (4)
CYDY CytoDyn Inc
10/14/2024 4:08:06 PM
What they might be suggesting needs (9)
CYDY CytoDyn Inc
10/06/2024 9:55:54 AM
I will just add this footnote to yo (15)
CYDY CytoDyn Inc
10/06/2024 9:42:52 AM
I think the board here should under (26)
CYDY CytoDyn Inc
10/04/2024 11:59:54 AM
“I don’t see this CEO getting s (17)
CYDY CytoDyn Inc
09/25/2024 1:01:35 PM
CRP reductions with Leronlimab in t (4)
CYDY CytoDyn Inc
09/24/2024 4:12:07 PM
“Leronlimab monotherapy (700 mg) (21)
CYDY CytoDyn Inc
09/20/2024 9:04:59 AM
It remains to let the results of th (28)
CYDY CytoDyn Inc
09/14/2024 9:11:11 PM
I was living in Seattle, enrolled i (15)
CYDY CytoDyn Inc
09/06/2024 10:23:13 AM
On February 1, Cytodyn announced in (4)
CYDY CytoDyn Inc
08/27/2024 9:32:30 AM
I was just looking at the SMC websi (17)
CYDY CytoDyn Inc
08/26/2024 2:29:01 PM
“How about conjugating LL with a (9)
CYDY CytoDyn Inc
08/26/2024 10:17:10 AM
“Not even a pre-clinical murine s (4)
CYDY CytoDyn Inc
08/26/2024 7:25:41 AM
The FDA would likely not approve a (3)
CYDY CytoDyn Inc
08/24/2024 7:20:46 PM
I have a hunch that the mouse MASH (16)
CYDY CytoDyn Inc
08/23/2024 4:43:35 PM
My memory if accurate was a 90 day (12)
CYDY CytoDyn Inc
08/23/2024 2:52:35 PM
“ intended to convey a speculativ (15)
CYDY CytoDyn Inc
08/23/2024 11:56:34 AM
Cytodyn may well be engaging Syneos (14)
CYDY CytoDyn Inc
08/15/2024 11:54:13 AM
This observation in the second hype (12)
CYDY CytoDyn Inc
08/15/2024 11:21:34 AM
Excellent summary OHM20. There is s (5)
CYDY CytoDyn Inc
08/14/2024 11:37:15 AM
Warning, objects are closer than th (12)
CYDY CytoDyn Inc
08/14/2024 8:36:59 AM
Assuming for a minute the MSS CRC t (10)
CYDY CytoDyn Inc
08/13/2024 6:47:06 PM
Add in the bone marrow suppression (8)
CYDY CytoDyn Inc
08/13/2024 5:36:05 PM
Again, clarity will come when the t (8)
CYDY CytoDyn Inc
08/13/2024 4:22:22 PM
It will be useful to get clarificat (18)
CYDY CytoDyn Inc
08/12/2024 10:25:11 AM
I agree with Respert, buttoning dow (28)
CYDY CytoDyn Inc
07/23/2024 3:45:37 PM
The FDA doesn’t slap a black box (8)
CYDY CytoDyn Inc
07/23/2024 11:52:28 AM
As a clinician his primary interest (15)
CYDY CytoDyn Inc
07/18/2024 5:03:11 PM
“CCR5 and CCL5 in metastatic colo (16)
CYDY CytoDyn Inc
07/17/2024 3:01:57 PM
The thing that turns investors head (10)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Neogen Corporation Investors Can Join Class Action Efforts
  • Key Actions for Luminar Technologies Investors Amid Class Action
  • Investors Urged to Act: RxSight Class Action Deadline Approaches
  • Sable Offshore Corp. Class Action: Important Actions for Investors
  • Protecting Your Rights Following Securities Claims with TRSG
  • Investors of Fiserv, Inc. Can Join Class Action for Losses
  • Kepler's K2 Humanoid Robot Revolutionizes Industrial Automation
  • Investor Rights Firm Investigates Potential Mergers and Sales
  • Investigating Stockholder Rights: Olo, Fubo, Arcadia, and Norfolk
  • RxSight Inc. Faces Class Action Lawsuit Over Misleading Claims
  • Spitzer Autoworld Elevates Customer Experience with New VIP Program
  • HashJ Launches New BTC Participation Contracts Amid Market Shift
  • Experience Vibrant Music Events at Great Park Live This Season
  • Explore OLIVE YOUNG's K-Beauty Innovations at KCON LA 2025
  • Discovering the Exceptional Growth of Gartner Stock Today
  • Investors of Sable Offshore Corp. Encouraged to File Claims
  • Senate Bill Secures Funding for OSHA and NIOSH - A Win for Safety
  • Arteris, Inc. Boosts Team with New Inducement Stock Awards
  • Investing in Ameriprise Financial: A 5-Year Review
  • Grupo Cox Makes Major Investment with Iberdrola Acquisition
  • First National Bank Alaska Announces Strong Q3 Dividend Strategy
  • Understanding the Long-Term Value of American Express Stock
  • First National Bank Alaska Announces Third Quarter Dividend
  • Project 61 and Offshift Join Forces for Truck Driver Health
  • Keg Royalties Income Fund Secures Approval for Fairfax Deal
  • The Keg Royalties Income Fund Secures Approval for Key Deal
  • Unlocking the Wealth from Shopify: 15 Years of Growth Insights
  • Lara's Rate Hikes: Consumers Left in Uncertainty Amid Secrecy
  • Barrett-Jackson Holdings Responds to Customer Data Breach
  • A Decade of Growth: $100 in Live Nation Entertainment's Journey
  • Crypto Market Surges—Will the Bull Momentum Continue?
  • Hims & Hers: A Bright Future Amidst Market Challenges
  • OZAK AI Raises $1.5M in Presale, Captivating AI Investors
  • Investigation into Corporate Governance of Key Companies
  • How A Small Investment In McKesson Grew Over 5 Years
  • PSEG Urges Shareholders to Avoid Mini-Tender Offers by TRC Capital
  • Investing in Canadian Natural Resources: A 5-Year Journey
  • Exploring Energy Transfer's Impressive Five-Year Growth
  • TTEC's Leadership Reassures Stakeholders Amid Changes
  • Grupo Cox's Landmark Acquisition Reshapes Energy Landscape
  • Navigating Market Trends: Insights into Seasonal Volatility
  • Navigating the Securities Class Action for Investors of RCKT
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site